Skip to content
Search AI Powered

Latest Stories

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.


New data from the House of Commons Library reveals that the number of pharmacies across England and Wales has fallen by 8%, dropping from 12,204 in September 2016 to just 11,184 by January 2025.

The analysis found that 77% of the 440 constituencies across England and Wales have experienced a decline in pharmacy numbers over the past decade. Some areas have been hit particularly hard — with Feltham and Heston, Bristol East, and Newbury each losing around a third of their pharmacies.

The Liberal Democrats, who commissioned the research, warned that "pharmacy deserts" are becoming "normalised" and urged the government to introduce urgent support measures, including tax relief for pharmacies.

“The government recognises that pharmacies play a vital role in our healthcare system,” said Kinnock.

“We are committed to expanding the role of pharmacies and better utilising the skills of pharmacists and pharmacy technicians.”

“Employers clearly have a key role in retaining staff and making jobs in community pharmacy attractive.”

“To support employers, NHS England has provided a number of fully funded national training opportunities for pharmacists and pharmacy technicians to help support private contractors to deliver quality National Health Services, including Pharmacy First.”

He also confirmed that the government has concluded its consultation on funding for 2024/25 and 2025/26, reaching an agreement with Community Pharmacy England to increase the community pharmacy contractual framework to £3.073 billion.

“This deal represents the largest uplift in funding of any part of the NHS, over 19% across 2024/25 and 2025/26,” Kinnock added.

“This shows a commitment to rebuilding the sector.”

The National Pharmacy Association (NPA) has welcomed the new funding deal as a “clear step forward,” but warned that it still leaves pharmacies facing a £2.5 billion shortfall, as highlighted by an NHS-commissioned independent economic analysis.

The NPA has long cautioned about the growing risk of “pharmacy deserts,” with patients in rural and isolated areas increasingly struggling to access vital services from their local pharmacies.

The latest data from the NHS Business Services Authority (NHSBSA) also shows that the number of bricks-and-mortar community pharmacies in England has fallen below 10,000 for the first time in 20 years.

As of the end of March 2025, there were 9,999 community pharmacies (excluding distance-selling pharmacies) operating in England — down from 10,837 at the start of 2021. This represents a net loss of 838 pharmacies over four years.

Between January 2024 and March 2025 alone, England saw 274 pharmacy closures — an average of more than five closures per week.

The most recent Workforce Wellbeing Survey, conducted by the Royal Pharmaceutical Society (RPS) in partnership Pharmacist Support, revealed that 87% of pharmacy professionals were at high risk of burnout, with nearly half of the workforce negatively impacted by financial pressures.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less